https://thehealthtechsignal.com/signal/2026-11-02 The HealthTech Signalen 2026-11-02T09:00:00.000Z CT-Guided PCI Planning Matches Ultrasound Outcomes in Heartflow Clinical Trial https://thehealthtechsignal.com/article/p4-trial-ct-ivus-upstream-pci-planning The HealthTech Signalen 2026-11-02T09:00:00.000Z Planning Moves Upstream: What the P4 Trial Means for CT, IVUS and the Economics of the Cath Lab https://thehealthtechsignal.com/article/voceryq-cellectra-device-delivered-dna-medicine The HealthTech Signalen 2026-11-02T09:00:00.000Z Device and Drug as One Product: VOCERYQ, CELLECTRA and the Commercial Test for DNA Medicines https://thehealthtechsignal.com/article/australia-cdss-exemption-clinical-ai-transparency The HealthTech Signalen 2026-11-02T09:00:00.000Z Show Your Working: Australia's CDSS Exemption, the AI Scribe Review and the Transparency Test for Clinical AI https://thehealthtechsignal.com/newsletters/ct-guided-pci-planning-matches-ivus-in-the-1-105-patient-p4-trial-at-tct-2026 The HealthTech Signalen 2026-11-02T08:00:00.000Z CT-Guided PCI Planning Matches IVUS in the 1,105-Patient P4 Trial at TCT 2026